Table 4.

Multivariate analysis for 1‐year mortality after HTX

Variable	Hazard ratio	95% CI	P‐value
Complete RBBB ≤ 30 days after HTX (in total)	2.20	1.68–2.87	<0.01*
Recipient age (decades)	1.20	1.08–1.33	<0.01*
Recipient preoperative PVR (Wood units)	1.13	1.04–1.22	<0.01*
Recipient COPD (in total)	2.92	2.33–3.66	<0.01*
Recipient severely reduced 30‐day RV function (in total)	9.38	5.76–15.28	<0.01*
Recipient severely reduced 30‐day LV function (in total)	5.96	3.08–11.54	<0.01*
Donor age (decades)	1.02	0.94–1.10	0.70
Ischaemic time (hours)	1.00	0.90–1.10	0.94

ACE inhibitor, angiotensin‐converting‐enzyme inhibitor; ARB, angiotensin II receptor blocker; CI, confidence interval; COPD, chronic obstructive pulmonary disease; HTX, heart transplantation; LV, left ventricle; PVR, pulmonary vascular resistance; RBBB, right bundle branch block; RV, right ventricle.

^*Statistically significant at P < 0.05.